Correlation Between Valneva SE and Opus Genetics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Opus Genetics,, you can compare the effects of market volatilities on Valneva SE and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Opus Genetics,.

Diversification Opportunities for Valneva SE and Opus Genetics,

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Valneva and Opus is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Valneva SE i.e., Valneva SE and Opus Genetics, go up and down completely randomly.

Pair Corralation between Valneva SE and Opus Genetics,

Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Opus Genetics,. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.55 times less risky than Opus Genetics,. The stock trades about -0.2 of its potential returns per unit of risk. The Opus Genetics, is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  91.00  in Opus Genetics, on September 17, 2024 and sell it today you would earn a total of  9.00  from holding Opus Genetics, or generate 9.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Valneva SE ADR  vs.  Opus Genetics,

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Opus Genetics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Valneva SE and Opus Genetics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and Opus Genetics,

The main advantage of trading using opposite Valneva SE and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.
The idea behind Valneva SE ADR and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities